Job Description

The U.S. healthcare system is complex and evolving.   For AbbVie to lead the industry in this environment, it is vital that our US Market Access (USMAx) Strategy and Pipeline Team thoroughly comprehend the current and future state of the evolving U.S. healthcare space and market access channels. 

The Director, USMAx Pipeline, Neuroscience & Toxins will lead U.S. market access strategy development for early pipeline priority assets within the broad AbbVie Neuroscience and Eyecare franchise, focused mainly on Toxin and Migraine assets.  The Director USMAx Pipeline will help integrate the understanding of the complex U.S. health system and the needs and requirements of U.S. payers into early asset development and bring the voice of U.S. payers to our early drug development process.   The ideal candidate will have a strong understanding of US private and public payer segments, medical benefit reimbursement, buy and bill and the IRA. The candidate can think strategically and critically and build strong and trusting relationships for cross functional influence and is able to fully and properly represent US Market Access in pipeline governance and business development discussions (as required).

The Director will align with cross-functional colleagues in Pipeline Commercialization Strategy (PCS) and Commercial Leadership to determine USMAx project and deliverable prioritization and lead delivery of such projects.  The role will ensure integration within the AbbVie Pipeline Commercialization Model including co-leadership of the Value and Access Teams (VATs) with International Market Access (IMAP) Colleagues and lead creation of US EIVPs (Early Integrated Value Proposition) and Integrated Access Strategy. The Director will also participate within Asset Strategy Team discussions and provide leadership within other Pipeline Commercialization Model teams as needed. The ideal candidate should have a track record of building deep cross-functional stakeholder alignment, experience in U.S. payer marketing strategy development, and an understanding of the AbbVie Pipeline Commercialization Model. 

 Specific Accountabilities Include:

·        Lead the creation of Integrated Asset Strategies, Disease Area Strategies and Early Integrated Value Propositions within the AbbVie Neuroscience & Toxin Portfolio and collaborate with Teams across BUs, IMAP, Medical, HEOR, IRA, R&D and others to ensure the value drivers of USMAx Decision Makers are incorporated into Pipeline Commercialization Strategies.

·        Inform Clinical Development Programs such that endpoints and evidence generation plans (i.e. clinical, economic and humanistic outcomes) are incorporated that will support optimized patient access.

·        Ensure project resource needs are met; secure and allocate budget across asset assignments to meet critical enterprise goals for Pipeline assets.

·        Inform early asset development especially through Touchpoints of 1-7-5 focused on market access evidence requirements and market shaping opportunities.

·        Ensure that deep USMAx insights are embedded consistently in all Early Pipeline Touchpoints and that strategies to support optimal asset development and market shaping are initiated in a timely fashion until hand-off to Sr. Directors, MAx Marketing for launch preparation.

·        Provide strong asset leadership representing USMAx Pipeline as the point of contact for Toxin and Migraine stakeholders

·        Act as a critical partner to key internal stakeholders who drive early pipeline strategy including US Commercial Leadership, Asset Strategy Leadership, Pipeline Commercial Strategy Leadership, Medical Affairs/HEOR and International Market Access and Pricing.

·        Represent USMAx Early Pipeline at governance as needed (e.g., TASC, Toxin office, DRG, etc.)

·        Contribute critical strategic thinking to inform access and pricing assumptions to create accurate, market driven LRP assumptions for Toxin & Migraine pipeline assets.  Coordinate and act as pipeline lead for USMAx for financial LRP and strategic LRP for assigned assets.

·        Work closely across USMAx Teams to stay close to channel customer dynamics and priorities, partner with IRA and strategy team to ensure optimal asset planning